| 发明名称 |
COMPOSITIONS FOR TREATMENT OF CARDIOMETABOLIC DISORDERS |
| 摘要 |
The present invention provides for methods of preventing or improving cardiometabolic disorders/metabolic disorders, compositions and pharmaceutical compositions comprising therapeutically effective amount of therapeutic phospholipid compositions and therapeutically effective amount of one or more lipid modifying agents, including statins. |
| 申请公布号 |
US2015038469(A1) |
申请公布日期 |
2015.02.05 |
| 申请号 |
US201414201375 |
申请日期 |
2014.03.07 |
| 申请人 |
Neptune Technologies & Bioressources, Inc. |
发明人 |
Sampalis Fotini |
| 分类号 |
A61K31/661;A61K31/40;A61K31/47;A61K31/216;A61K31/405;A61K31/505;A61K31/44;A61K31/366 |
主分类号 |
A61K31/661 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treating a cardiometabolic disorder/metabolic syndrome, the method comprising administering a therapeutically effective amount of a lipid modifying agent and a composition comprising therapeutically effective amount of a phospholipid comprising a glycerol baclbone wherein one of the sn-1 and sn-2 positions is selected from a docosahexaenoic acid (DHA) or an eicosapentaenoic acid (EPA) residue and the other sn-1 and sn-2. position is a fatty acid, to a subject in need thereof. |
| 地址 |
Laval CA |
